1Mckay JA,Douglas J J,Ross VG,et al.Analysis of key cell-cycle checkpoint proteins in eolorectal tumours [J].Pathol,2002;196(4):386 ~ 393
2Sui L,Tokuda M,Ohno M,et al.The concurrent expression of p27(kipl) and cyclin D1 in epithe-lial ovarian tumors [J].Cynecologic Oncology,1999;73(2):202 ~ 209
3Bae DS,Cio SB,Kim YJ,et al.Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus[J].Gynecologic Oncology,2001,81(3):341 ~ 347
4Takano Y Takenaka H,Kato Y et al.Cyclin D1 overexpression in invasive breast cancers:correlation with cyclin dependent kinase 4 and cestrogen receotor overexpression,and lack of correlation with mitotic activity [J].Cancer Res Clin Oncol,1999;125:505 ~512
5Naidu R,Wanhab NA,Yadv MM,et al.Expression and amplification of Cyclin D1 in primary breast carcinomas relationship with histopathological types and clinico-pathological parameters [J].Oncol Rep,2002;9(2);403 ~ 416
6Sui L,Dong Y Ohno M,et al.Inverse expression of cdk4 and p16 in epithelial ovarian tumors [J].Cynecologic Oncology,2000;79(2):230~ 237
7Tsuda H,Yamamoto K,Inoue T,et al.The role of p16-cyclinD/CDK-pRb pathway in the tumorigenesis of endometried-type endometrial carcinoma [J].Br J Cancer,2000;82(3):675 ~ 682
8Semczuk A,Miturski R,Skomra D,et al.Expression of the cell-cyle regulatolfy proteins (pRb,cyclin D1,p16INK4A and cdk4) in human endometrial cancer:correlation with clinicopathological features [J].Arch Gynecol Obstet,2004;269(2):104 ~ 110
9Hwandner O,Bruch HP,Broll R.p21,p27,cyclin D1 and p53 in rectal cancer:immunohistology with prognostic significance [J].Int J Colorecial Dis,2002;17(1):11 ~ 19
10BukholmI K,NeslandJM.Protein expression of p53,p21 (WAF1/CIP1),bcl-2,Bax,cyclin D1 and pRb in human colon carcinomas[J].Virchows Arch,2000;436:224 ~ 228
2Gillett C, Fanti V, Smith R, et al. Amplification and overexpression of Cyclin D1 in breast cancer detected by immunohistochemical staining [J] . Cancer Res, 1994, 54 (7) : 1812.
3Kamb A, Gruis NA, Weaver Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types [ J] . Science, 1994, 264 (5157): 436.
4Shimizu M, Saitch Y, Itoh H. Immunohistochemical staining of Hras oncogene product in normal, benign and malignant human pancreatic tissues [J] . Hum Pathol, 1990, 21 (1) : 607.
5Nakagawa H, Zukerberg L, Togawa K, et al. Human Cyclin D1 oncogene and esophageal squamous cell carcinoma [JJ . Cancer, 1995, 76 (4) : 541.
6JiriL, Louise A, Michael S, et al. Oncogenic aberrations of p16 in K4, CDK2 and Cyclin D1 cooperate to deregulate G1 control [J] . Cancer Res, 1995, 55:4818.
7Kamb A,Gruis NA,Waever-Frldhaus J,et al.A cell cycle regu1ator Potentially involved in genesis of many tumor types[J].Science,1994,264(5157):436-440.
8Lawson RA,Parr RA,Cahill LP.Evidence for maternal control of blastocyst growth after asynchronous transfer of embryos to the uterus of the ewe[J].J Reprod Fertil,1983,67(2):477-483.
9日本生理学会.生理学实验[M].第3版,北京:人民卫生出版社,1980:180-182.
10Okano A,Ogawa H,Takahashi H,et al.Apotosis in the porcine uterine endometrium during the estrous cycle,early pregnancy and post partum[J].Reprod Dev,2007,53(4):923-930.